Moderating Factors in an Anti-stigma Intervention for African American Women with HIV in the United States: A Secondary Analysis of the UNITY Trial.
Katrin E FabianDavid HuhChristopher G KempPaul E NevinJane M SimoniMichele AndrasikJanet M TuranSusan E CohnMichael J MugaveroDeepa RaoPublished in: AIDS and behavior (2019)
African American women experience higher rates of HIV than other women in the United States, and stigma has been identified as an important determinant of engagement in HIV care. Our study examined whether key variables moderated the effect of an anti-stigma intervention on outcomes among African American women receiving treatment for HIV. Twelve potential moderators included: age, years lived with HIV, marital status, employment status, education level, PTSD diagnosis, alcohol use, social support, baseline CD4 count, baseline viral load, and number of children. Outcomes included changes in: HIV-related stigma, social support, depressive symptoms, PTSD symptoms, alcohol use, viral load, and engagement in HIV care. Results suggest that the intervention is associated with greater improvement in engagement in care among participants with PTSD or depression at baseline, and may help maintain engagement in care among participants experiencing certain mental health conditions. This provides opportunities to address discriminatory structural barriers that lead to stigma and drop-offs in HIV care.
Keyphrases
- social support
- african american
- depressive symptoms
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- hiv aids
- human immunodeficiency virus
- hepatitis c virus
- mental health
- men who have sex with men
- healthcare
- randomized controlled trial
- social media
- sleep quality
- polycystic ovary syndrome
- young adults
- south africa
- mental illness
- pregnancy outcomes
- type diabetes
- pregnant women
- adipose tissue
- affordable care act
- smoking cessation
- posttraumatic stress disorder
- replacement therapy